Microba Life Sciences (ASX:MAP) Net Change in Cash : A$-14.11 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Microba Life Sciences's Net Change in Cash for the six months ended in Dec. 2023 was A$-4.20 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was A$-14.11 Mil.

Microba Life Sciences Net Change in Cash Historical Data

The historical data trend for Microba Life Sciences's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Net Change in Cash Chart

Microba Life Sciences Annual Data

Trend

Jun22

Jun23

Net Change in Cash

17.60

1.46

Microba Life Sciences Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Net Change in Cash	-	-	11.37	-9.91	-4.20

Microba Life Sciences Net Change in Cash Calculation

Microba Life Sciences's Net Change in Cash for the fiscal year that ended in Jun. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-12.394	+	-2.999	+	16.684	+	0.171
	=	1.46

Microba Life Sciences's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -11.575 + -11.29 + 18.534 + 0.132

= -4.20

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-14.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microba Life Sciences Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Microba Life Sciences's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences (ASX:MAP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Net Change in Cash

Comparable Companies

ASX:GSS ASX:IIQ ASX:RHY ASX:LDX ASX:CTE ASX:GTG ASX:BDX ASX:IBX TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX

Traded in Other Exchanges

N/A

Address

324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000

Website

https://www.microba.com

Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines